UNUnitedHealth Group statistics
$407.46+0.58%Close 13 Nov 2026
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
| Enterprise value | $418.3B |
|---|
| EV / EBITDA | 14.84 |
|---|
| EV / sales | 0.93 |
|---|
Share price
| Latest close | $407.46 |
|---|
| Day's change | +0.6% |
|---|
| 52-week high | $461.62 |
|---|
| 52-week low | $255.97 |
|---|
| From 52-week high | −11.7% |
|---|
| Return · 1 month | +1.5% |
|---|
| Return · 3 months | +5.9% |
|---|
| Return · year to date | +23.4% |
|---|
| Return · 1 year | +20.2% |
|---|
| Beta · 1 year against the S&P 500 | 0.35 |
|---|
| 50-day average | $391.43 |
|---|
| 200-day average | $366.44 |
|---|
| RSI 14 | 55.3 |
|---|
| Average volume · 20 sessions | 4.9M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 4.2% |
|---|
| Net margin | 2.7% |
|---|
| Free cash flow margin | 3.6% |
|---|
| Return on equity | 12.2% |
|---|
| Return on assets | 5.4% |
|---|
| Return on invested capital | 8.1% |
|---|
| Return on capital employed | 9.7% |
|---|
| Stock-based compensation / revenue | 0.2% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $24.36B |
|---|
| Total debt | $82.30B |
|---|
| Net debt | $54.17B |
|---|
| Current ratio | 0.79 |
|---|
| Debt / equity | 0.82 |
|---|
| Net debt / EBITDA | 2.32 |
|---|
| Interest coverage | 4.74 |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 911M |
|---|
| Net share repurchases | $4.72B |
|---|
| Dividends per share | $8.73 |
|---|
| Dividend payout | 65.7% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $1.89B |
|---|
| Effective tax rate | 12.9% |
|---|
UNH in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.